期刊
BLOOD
卷 113, 期 5, 页码 1006-1015出版社
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2008-05-156059
关键词
-
类别
资金
- Italian Ministry of Health
- Italian Ministry of Research and University
- Fondazione Cariplo
- Italian Association for Cancer Research
Long-term clinical remissions of leukemia, after allogeneic hematopoietic stem cell transplantation, depend on alloreactive memory T cells able to self-renew and differentiate into antileukemia effectors. This is counterbalanced by detrimental graft-versus-host disease (GVHD). Induction of a selective suicide in donor T cells is a current gene therapy approach to abrogate GVHD. Unfortunately, genetic modification reduces alloreactivity of lymphocytes. This associates with an effector memory (T-EM) phenotype of gene-modified lymphocytes and may limit antileukemia effect. We hypothesized that alloreactivity of gene-modified lymphocytes segregates with the central memory (T-CM) phenotype. To this, we generated suicide gene-modified T-CM lymphocytes with a retroviral vector after CD28 costimulation and culture with IL-2, IL-7, or a combination of IL-7 and IL-15. In vitro, suicide gene-modified T-CM cells self-renewed upon alloantigen stimulation and resisted activation-induced cell death. In a humanized mouse model, only suicide gene -modified T cells cultured with IL-7 and IL-15 persisted, differentiated in T-EM cells, and were as potent as unmanipulated lymphocytes in causing GVHD. GVHD was halted through the activation of the suicide gene machinery. These results warrant the use of suicide gene modified T-CM cells cultured with IL-7 and IL-15 for the safe exploitation of the alloreactive response against cancer. (Blood. 2009;113:1006-1015)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据